When I joined the Colombian government’s Productive Transformation Program (PTP) as an International Advisor in early 2012, I had the opportunity of witnessing firsthand the changes taking place in the country in the field of competitiveness and innovation.
I frequently share with my European colleagues the enthusiasm and drive that I perceive in Colombian authorities, institutions and businessmen, their commitment to innovation and internationalization and their interest in supporting the technological sectors, and at the same time modernizing the so called mature sectors – on which the bulk of the GDP rests and hence the expectations for economic growth over the short term -.
Colombia is the second most mega-diverse country in the world: housing none other than 14% of the planet’s diversity
Fortunately, this enthusiasm is not only reflected in ambitious plans but rather in realities. The change taking place in the emerging field of Colombian biotechnology is a reality that merits review in this Inter-American Development Bank platform.
One of the most attractive aspects of biotechnology is that it consists of a very diverse set of technologies that can be applied in multiple sectors. It is an activity sector in itself, but also a competitive leverage for multiple sectors, mature users of these types of activities, which in some countries account for almost 30% of the GDP. This explains the interest that it sparks in both governments and organizations such as the European Union that launched its Bio-Economy Strategy “Innovating for Sustainable Growth” in 2012.